[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"narcotic-use\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:narcotic-use":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,50],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":33,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100372519","phase-4-intraperitoneal-infusion-of-analgesic-for-postoperative-pain-management-100372519",false,"NCT04130464","Intraperitoneal Infusion of Analgesic for Postoperative Pain Management","The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial","ON-Q","Inclusion Criteria:\n\n* Hysterectomy planned for a benign gynecologic reason (no evidence of, or concern for, malignancy in the cervix, uterus, tubes or ovaries. Benign gynecologic reasons to have a hysterectomy include fibroids, abnormal uterine bleeding, endometriosis, and pelvic pain.)\n* Patient is scheduled to have surgery with a fellowship trained minimally invasive gynecologic surgeons at one of the study sites.\n* Patient is planned for a robotic assisted total laparoscopic hysterectomy (RA-TLH) or a total laparoscopic hysterectomy (TLH).\n* Patient is capable of informed consent.\n* Patient is capable of completing the questionnaires.\n\nExclusion Criteria:\n\n* Concern for malignancy\n* The procedure is scheduled outside MIGS department.\n* Allergy to any study related medication (i.e. Ketorolac and Ropivacaine)\n* Patient is enrolled in another pain management study.",true,"FEMALE","18 Years","65 Years",{"count":22,"type":23},120,"ESTIMATED","INTERVENTIONAL",[26],"PHASE4","The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA combined with an NSAID compared with a control group who receives only 0.9% normal saline.",[29,30,31,32],"Hysterectomy","Gynecologic Surgical Procedures","Narcotic Use","Pain, Postoperative",[34,35,36,37],"Intraperitoneal","Pain Pump","Ropivacaine","Ketorolac Tromethamine","RECRUITING","2026-04-03",{"date":41,"type":42},"2026-04-09","ACTUAL",{"date":44,"type":42},"2019-09-30",{"date":46,"type":23},"2026-12",{"name":48,"class":49},"Ying Liu","OTHER",{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":17,"sex":57,"minAge":19,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":24,"phases":60,"briefSummary":63,"conditions":64,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100349131","phase-2-nonopioid-analgesia-after-labral-surgery-100349131","NCT03825809","Nonopioid Analgesia After Labral Surgery","Traditional vs. Nonopioid Analgesia After Labral Surgery","Eligibility Criteria:\n\nInclusion Criteria:\n\n* All adult patients over age 18 and scheduled for a primary or revision labral surgery\n\nExclusion Criteria:\n\n* Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff","ALL",{"count":59,"type":23},100,[61,62],"PHASE2","PHASE3","This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen",[31],"2019-01-30",{"date":67,"type":42},"2019-01-31",{"date":69,"type":42},"2019-01-22",{"date":71,"type":23},"2020-05-20",{"name":73,"class":49},"Henry Ford Health System",1]